Results 151 to 160 of about 7,099 (210)

Efficacy and Safety of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide Fumarate in Treating Acute-on-Chronic Liver Failure with Hepatitis B Virus: A Network Meta-analysis. [PDF]

Infect Dis Ther
Liu J, Bi Y, Ma X, Xin Y.
europepmc   +1 more source

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. [PDF]

Adv Ther (Weinh), 2021
Pons-Faudoa FP, Sizovs A, Shelton KA, Momin Z, Niles JA, Bushman LR, Xu J, Chua CYX, Nichols JE, Demaria S, Ittmann MM, Hawkins T, Rooney JF, Marzinke MA, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Ferrari M, Sastry KJ, Grattoni A.   +20 more
europepmc   +1 more source

Weight gain on tenofovir alafenamide fumarate-based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe. [PDF]

HIV Med
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group.
europepmc   +1 more source

Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial. [PDF]

BMJ Open, 2021
Wang L, Wu L, Li X, Zhang Y, Lai J, Zhu X, Xie C, Peng L.   +7 more
europepmc   +1 more source

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan. [PDF]

Viruses
Trizzino M, Gaudiano R, Arena DM, Pipitò L, Gioè C, Cascio A.   +5 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort. [PDF]

Eur J Hosp Pharm, 2023
Rotea-Salvo S, Martínez-Pradeda A, Fernández-Oliveira C, Giménez-Arufe V, Balboa-Barreiro V, Margusino-Framiñán L, Mena-De-Cea Á, Vázquez-Rodríguez P, Castro-Iglesias Á, López-Calvo S, Martín-Herranz I, Míguez-Rey E, Cid-Silva P.   +12 more
europepmc   +1 more source

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe [PDF]

, 2017
, , Lodwick, R.
core   +1 more source

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B. [PDF]

Virol J
Cao F, Fan T, Jiang X, Wang J, Liu Y, Zhu L, Xiong Y, Zhang S, Zhang Z, Pan Y, Li Y, Jiang C, Xia J, Yan X, Li J, Liu X, Zhu C, Huang R, Wu C.   +18 more
europepmc   +1 more source

Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial. [PDF]

BMC Pharmacol Toxicol
Yazdan Pouri N, Shokati Eshkiki Z, Talebi A, Cheraghian B, Ahmadi F, Neisi N, Shayesteh AA.   +6 more
europepmc   +1 more source